San Diego-primarily based Viking Therapeutics marked itself as a serious competitor inside the weight loss drug marketplace in February right after revealing promising information from a mid-stage demo of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when given as being a weekly injection and in Mar